SPONSOR
The First Hospital of Jilin University
Total Trials
9
Recruiting
9
Phases
Phase 2
Conditions studied: Relapsed/Refractory Multiple MyelomaPlasma Cell Leukemia (PCL)Lung Cancer (Diagnosis)Deep Vein Thrombosis (DVT)Venous Thromboembolism (VTE)Metastatic Colorectal CancerColorectal Neoplasms MalignantEndocytoscopyBreast CancerMRD
The First Hospital of Jilin University is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia (PCL), Lung Cancer (Diagnosis), Deep Vein Thrombosis (DVT).
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Hospital of Jilin University
How many clinical trials has The First Hospital of Jilin University sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by The First Hospital of Jilin University, of which 9 are actively recruiting participants. These trials cover conditions including Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia (PCL), Lung Cancer (Diagnosis). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Hospital of Jilin University research focus on?
The First Hospital of Jilin University clinical trials span Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia (PCL), Lung Cancer (Diagnosis), Deep Vein Thrombosis (DVT), Venous Thromboembolism (VTE), and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Hospital of Jilin University clinical trial?
To participate in a The First Hospital of Jilin University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Hospital of Jilin University trials with current recruitment status updated daily.
Clinical Trials by The First Hospital of Jilin University
NCT07509086 Phase 2
Recruiting
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
Relapsed/Refractory Multiple Myeloma
NCT07439991
Recruiting
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Lung Cancer (Diagnosis)
NCT07559760 Phase 2
Recruiting
New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
NCT06714903
Recruiting
Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer
Colorectal Neoplasms Malignant
NCT06982872
Recruiting
Comparison of the Diagnostic Performance of Different Artificial Intelligence Assisted Endocytoscopy for Colorectal Lesions
Endocytoscopy
NCT06918262
Recruiting
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
Breast Cancer
NCT06881043
Recruiting
The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
Locally Advanced Gastric Cancer
NCT06929949
Recruiting
The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal Gastrectomy
Gastroesophageal Junction (GEJ) Cancer
NCT06791408
Recruiting
Clinical Study on the Accuracy of Real-time AI-assisted Endocytoscopy in the Diagnosis of Colorectal Diminutive Polyps
Colorectal Polyp
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology